HSulf-2: A New Tool for Mobilizing Growth Factors from Heparin
Author Information
Author(s): Uchimura Kenji, Morimoto-Tomita Megumi, Bistrup Annette, Li Jessica, Lyon Malcolm, Gallagher John, Werb Zena, Rosen Steven D
Primary Institution: University of California, San Francisco
Hypothesis
Does HSulf-2 modulate the interactions between heparin-binding factors and heparin?
Conclusion
HSulf-2 can disrupt the binding of certain growth factors and chemokines to heparin, suggesting its potential role in regulating their availability.
Supporting Evidence
- HSulf-2 treatment significantly reduced the binding of VEGF and FGF-1 to heparin.
- Native Sulf-2 from MCF-7 cells reproduced the effects of recombinant HSulf-2.
- HSulf-2 can release heparin-bound ligands, enhancing their bioavailability.
Takeaway
HSulf-2 is like a special tool that helps release important proteins from heparin, which is a substance in our body. This can help these proteins do their jobs better.
Methodology
The study used ELISA to measure the binding of growth factors to immobilized heparin before and after treatment with HSulf-2.
Limitations
The study primarily focused on a limited number of growth factors and chemokines, which may not represent all interactions with heparin.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website